Alerts
PDF
Other content recommended for you
- Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
- Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips
- Rapid visual recovery following intravenous tocilizumab in glucocorticoid resistant refractory giant cell arteritis
- EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update
- Giant cell arteritis
- Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool
- Need and value of targeted immunosuppressive therapy in giant cell arteritis
- New headaches with normal inflammatory markers: an early atypical presentation of giant cell arteritis
- Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations
- Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort